Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin Disallow: /wp-includes Disallow: /wp-content/plugins Disallow: /wp-content/cache Disallow: |
Title | Avstera |
Description | Home About Us Pipeline Newsroom News Events Contact Us Avstera Home About Us Pipeline Newsroom News Events Contact Us Leading the next revolution for tack |
Keywords | N/A |
WebSite | avstera.com |
Host IP | 35.245.50.33 |
Location | United States |
Site | Rank |
US$1,414,257
Last updated: 2023-05-19 11:04:56
avstera.com has Semrush global rank of 7,484,007. avstera.com has an estimated worth of US$ 1,414,257, based on its estimated Ads revenue. avstera.com receives approximately 163,184 unique visitors each day. Its web server is located in United States, with IP address 35.245.50.33. According to SiteAdvisor, avstera.com is safe to visit. |
Purchase/Sale Value | US$1,414,257 |
Daily Ads Revenue | US$1,306 |
Monthly Ads Revenue | US$39,165 |
Yearly Ads Revenue | US$469,969 |
Daily Unique Visitors | 10,879 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
avstera.com. | A | 598 | IP: 35.245.50.33 |
avstera.com. | NS | 3600 | NS Record: ns53.domaincontrol.com. |
avstera.com. | NS | 3600 | NS Record: ns54.domaincontrol.com. |
avstera.com. | MX | 3600 | MX Record: 0 avstera-com.mail.protection.outlook.com. |
avstera.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
avstera.com. | TXT | 3600 | TXT Record: MS=ms73829409 |
Home About Us Pipeline Newsroom News Events Contact Us Avstera Home About Us Pipeline Newsroom News Events Contact Us Leading the next revolution for tackling solid tumors Learn More Leading the next revolution for tackling solid tumors At Avstera, our primary focus is to address the significant unmet need of advanced cancer patients who have limited or no treatment options. These include patients who fail to respond to existing therapies, or end up developing resistance to immunotherapy. With our proprietary pipeline of oncology programs, including an ultra-specific HDAC6i (AVS100), autologous HDAC6i activated macrophage-based cell therapy (AVS200), and mRNA cancer vaccine encoding TEM1 (AVS300), we will offer revolutionary solutions targeting solid tumors and addressing a significant unmet need for patients across all tumor types. 365 Phoenixville Pike Malvern, PA 19355 info@avstera.com Home About Us Pipeline Newsroom News Events Contact Us Copyright © 2023 · Avstera Therapeutics |
HTTP/1.1 301 Moved Permanently Date: Fri, 30 Sep 2022 08:20:12 GMT Server: Apache/2.4.46 (Unix) OpenSSL/1.1.1n Location: https://avstera.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Fri, 30 Sep 2022 08:20:12 GMT Server: Apache/2.4.46 (Unix) OpenSSL/1.1.1n Content-Type: text/html; charset=UTF-8 |
Domain Name: AVSTERA.COM Registry Domain ID: 2621905534_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-07-28T11:10:19Z Creation Date: 2021-06-24T11:53:42Z Registry Expiry Date: 2024-06-24T11:53:42Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS53.DOMAINCONTROL.COM Name Server: NS54.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-09-30T08:19:38Z <<< |